Investor Talk #5 - Angelor Santé
Wed, Oct 21
|The HIVE by Kadans Science Partner
Marie Chambodut, CEO at Angelor Santé will share their investment strategy and priorities for 2026, to PSCC Connect start-ups only.
Time & Location
Oct 21, 2026, 5:30 PM – 7:00 PM
The HIVE by Kadans Science Partner, 125 rue Edouard Vaillant, 94800 Villejuif, France
About the event
Investors Talks is a new event series dedicated to PSCC Connect start-ups only : an unfiltered meeting giving entrepreneurs direct access to leading investors in life sciences.
For the fifth edition, we will welcome Marie Chambodut, CEO at Angelor Santé
who will give us a behind-the-scenes view of how a VC assesses scientific innovation, management teams, and market potential in today's highly competitive funding environment.
The discussion will cover:
Angelor's 2026/2027 investment strategy: a strategic outlook on how this Lyon-based capital-innovation fund supports healthcare and biotech ventures within its broader approach.
How Angelor evaluates and selects promising, high-impact companies.
What makes a company investable in today's funding landscape.
Common pitfalls startups encounter when approaching VCs.
This afterwork will leave plenty of time for discussion and networking.
From how VCs truly assess opportunities to the type of relationships they seek to build, participants will gain practical, no-filter insights to better navigate their fundraising journey.